Product
180 mg controlled release form
1 clinical trial
1 indication
Indication
HealthyClinical trial
A Phase 1, Single Center, Randomized (2-Sequence), Single Blind, 3-Period Study Comparing the Safety, Tolerability, and Pharmacokinetics of Ecopipam Controlled Release Capsules With Ecopipam HCl Immediate Release Tablets in Male Adult VolunteersStatus: Completed, Estimated PCD: 2012-02-01